Skip to main content
. 2022 Jan 12;6(1):BJGPO.2021.0208. doi: 10.3399/BJGPO.2021.0208

Table 2. Univariate associations with NSAID prescription at baseline.

Characteristic Odds ratioa 95% CI P-value
Age group, years (versus 18–40) 40–59 2.20 2.11 2.29 0.02
60–79 2.59 2.48 2.71 <0.001
≥80 1.29 1.20 1.39 <0.001
Sex (versus male) Female 1.22 1.19 1.26 <0.001
Socioeconomic status, IMD quintile (versus 5, least deprived) 4 1.06 1.01 1.10 <0.001
3 1.15 1.10 1.20 <0.001
2 1.29 1.23 1.35 <0.001
1 (most deprived) 1.54 1.47 1.61 <0.001
CKD (versus no CKD) 1.00 0.94 1.06 0.96
CVD (versus no CVD) 0.80 0.76 0.85 <0.001
Heart failure (versus no heart failure) 0.51 0.44 0.59 <0.001
Diabetes (type 1 or 2 versus no diabetes) 1.31 1.26 1.37 <0.001
Hypertension (versus no hypertension) 1.44 1.39 1.49 <0.001
Osteoarthritis (versus no osteoarthritis) 2.82 2.73 2.91 <0.001
Rheumatoid arthritis (versus no rheumatoid arthritis) 5.08 4.71 5.47 <0.001

aFor those with multiple categories odd ratios were compared with base groups. CKD = chronic kidney disease. CVD = cardiovascular disease. IMD = Index of Multiple Deprivation. NSAID = non-steroidal anti-inflammatory drug.